Delivery Order SPE2DR25D3110-SPE2DR26F8EA5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,620.93 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count) with a firm fixed price structure. This non-set-aside award, issued on July 11, 2025, will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $9,739.52 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by December 23, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,739.52 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count packages) on November 7, 2025, with completion scheduled for December 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $14,609.25 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by December 5, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a ceiling value of $9,241.86. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $14,609.25 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count packaging) on November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 18, 2025. The award is performed from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $14,609.25 delivery order to AmerisourceBergen Drug Corp for supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract. The award, issued on November 3, 2025, with completion expected by November 25, 2025, represents a non-competitive set-aside delivery order executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is a child contract under the larger SPE2DX...
- The Defense Logistics Agency awarded a $6.01K delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive, non-set-aside award. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,862.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This non-set-aside competitive award is scheduled for completion by November 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this...
- The Defense Logistics Agency awarded a $13,862.79 delivery order to AmerisourceBergen Drug Corp for Zeposia 0.92 mg capsules (30-count units) on September 10, 2025, with an ultimate completion date of October 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial...
- SPE2DR25D3110Indefinite Delivery Contract
- SPE2DR25D3110-SPE2DR26F8EA5Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $14,609.25 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count units) under contract number 4570186290. This non-competitive delivery order is scheduled for completion by December 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive capability in delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 12/4/25 |